Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 4/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29388348 | 1.00 | ERN1 (0.51) | ERN1MAOBTRPM4ALDH1A1HSD17B10 | |
| SCHEMBL30828518 | 0.86 | ERN1 (0.45) | ERN1MAOBTRPM4ALDH1A1HSD17B10 | |
| SCHEMBL11784209 | 0.85 | ERN1 (0.44) | ERN1MAOBALDH1A1HSD17B10HIF1A | |
| SCHEMBL10484132 | 0.85 | HPRT1 (0.56) | ERN1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL7051109 | 0.83 | CYP1A2 (0.54) | ERN1MAOBALDH1A1HSD17B10HIF1A | |
| SCHEMBL19182198 | 0.83 | ALDH1A1 (0.60) | ERN1ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL2845190 | 0.81 | ALDH1A1 (0.50) | MAOBTRPM4ALDH1A1HSD17B10HIF1A | |
| SCHEMBL13347744 | 0.79 | ERN1 (0.46) | ERN1MAOBALDH1A1HSD17B10HIF1A | |
| SCHEMBL3415931 | 0.79 | ALDH1A1 (0.46) | ERN1MAOBTRPM4ALDH1A1HSD17B10 | |
| SCHEMBL10348693 | 0.79 | POLB (0.49) | ERN1ALDH1A1HSD17B10HIF1ACYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 382 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250136445-A1 | HYDROGEN PEROXIDE MANUFACTURING PROCESS AND MANUFACTURING SYSTEM BASED ON PHOTOCHEMICAL REACTION | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-05-01 | — | — | US | claimed |
| CN-119219504-A | Method for synthesizing triarylmethane molecular skeleton by aromatic aldehyde and hydrazine hydrochloride substance | 山东金科力电源科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| US-20240417252-A1 | ORGANIC WORKING SOLUTION FOR PHOTOCHEMICAL HYDROGEN PEROXIDE PRODUCTION AND METHOD FOR PRODUCING HYDROGEN PEROXIDE BY PHOTO-AUTOXIDATION UTILIZING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-12-19 | — | — | US | claimed |
| US-20240375955-A1 | PHOTOCHEMICAL HYDROGEN PEROXIDE PREPARATION PROCESS PERFORMED BY COMBINING PHOTOAUTOXIDATION AND PHOTOCATALYTIC REACTIONS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-11-14 | — | — | US | claimed |
| US-9018409-B2 | Process for functionalization of unsaturated compounds | MEURICE R&D ASBL (BE) | 2015-04-28 | — | — | US | claimed |
| EP-2632886-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | Meurice R&D ASBL (BE) | 2013-09-04 | — | — | EP | claimed |
| US-20130211033-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | MEURICE R&D ASBL (BE) | 2013-08-15 | — | — | US | claimed |
| WO-2012055946-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | MEURICE R&D ASBL (BE) | 2012-05-03 | — | — | WO | claimed |
| US-20040132807-A1 | Aurones as telomerase inhibitors | PHARMACIA ITALIA SPA (IT) | 2004-07-08 | — | — | US | claimed |
| EP-1381359-A1 | AURONES AS TELOMERASE INHIBITORS | Pharmacia Italia S.p.A. (IT) | 2004-01-21 | — | — | EP | claimed |
| WO-2002083123-A1 | AURONES AS TELOMERASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2002-10-24 | — | — | WO | claimed |
| US-5780250-A | Immunoassay standards for polyaromatic hydrocarbon detection | STRATEGIC DIAGNOSTICS, INC. (US) | 1998-07-14 | — | — | US | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| WO-1997031267-A1 | IMMUNOASSAY STANDARDS FOR POLYAROMATIC HYDROCARBON DETECTION | STRATEGIC DIAGNOSTICS, INC. (US) | 1997-08-28 | — | — | WO | claimed |
| US-5334665-A | Dispersant for carbon black, graphite; flow control agents | BRIDGESTONE/FIRESTONE, INC. (US) | 1994-08-02 | — | — | US | claimed |
| US-5210144-A | Polymers for tire tread | BRIDGESTONE CORPORATION (JP) | 1993-05-11 | — | — | US | claimed |
| US-5210145-A | Tires, reduced rolling resistance | BRIDGESTONE/FIRESTONE, INC. (US) | 1993-05-11 | — | — | US | claimed |
| US-4380629-A | Styryl-like compounds showing a color-developing and bleaching behavior with improved stability and prolonged lifetime | MATSUSHITA ELECTRIC INDUSTRIAL COMPANY, LIMITED (JP) | 1983-04-19 | — | — | US | claimed |
| US-4147862-A | Method of preparing styryl-like compounds | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1979-04-03 | — | — | US | claimed |
| JP-3127791-A | — | — | None | — | — | JP | disclosed |
| US-20260093180-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION FOR FILM FORMATION | JSR CORPORATION (JP) | 2026-04-02 | — | — | US | disclosed |
| CN-121574128-A | Pyrimidine-hydroxamic acid compounds and uses thereof | 华东理工大学 | 2026-02-27 | — | — | CN | disclosed |
| EP-4663636-A2 | TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS | BioCryst Pharmaceuticals, Inc. (US) | 2025-12-17 | — | — | EP | disclosed |
| US-20250270171-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2025-08-28 | — | — | US | disclosed |
| US-20250257040-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2025-08-14 | — | — | US | disclosed |
| EP-4180424-B1 | SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS | BIOCRYST PHARM INC (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20250136445-A1 | HYDROGEN PEROXIDE MANUFACTURING PROCESS AND MANUFACTURING SYSTEM BASED ON PHOTOCHEMICAL REACTION | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-05-01 | — | — | US | disclosed |
| WO-2025061216-A1 | COORDINATION COMPOUNDS OF RUTHENIUM AND OSMIUM FOR USE IN THE TREATMENT OF LUNG CANCER | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2025-03-27 | — | — | WO | disclosed |
| CN-119678105-A | Method for producing semiconductor substrate and composition for film formation | JSR株式会社 | 2025-03-21 | — | — | CN | disclosed |
| CN-119219504-B | Method for synthesizing triarylmethane molecular skeleton by aromatic aldehyde and hydrazine hydrochloride substance | 山东金科力电源科技有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20250011330-A1 | Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors | LEIDOS BIOMEDICAL RESEARCH INC. | 2025-01-09 | — | — | US | disclosed |
| CN-119219504-A | Method for synthesizing triarylmethane molecular skeleton by aromatic aldehyde and hydrazine hydrochloride substance | 山东金科力电源科技有限公司 | 2024-12-31 | — | — | CN | disclosed |
| US-20240417252-A1 | ORGANIC WORKING SOLUTION FOR PHOTOCHEMICAL HYDROGEN PEROXIDE PRODUCTION AND METHOD FOR PRODUCING HYDROGEN PEROXIDE BY PHOTO-AUTOXIDATION UTILIZING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-12-19 | — | — | US | disclosed |
| US-12162838-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240375955-A1 | PHOTOCHEMICAL HYDROGEN PEROXIDE PREPARATION PROCESS PERFORMED BY COMBINING PHOTOAUTOXIDATION AND PHOTOCATALYTIC REACTIONS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-11-14 | — | — | US | disclosed |
| US-12116346-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2024-10-15 | — | — | US | disclosed |
| CN-118725333-A | Keggin type polyacid-based metal organic framework molecular material, synthesis method and application of Keggin type polyacid-based metal organic framework molecular material as photocatalyst | 周口师范学院 | 2024-10-01 | — | — | CN | disclosed |
| CN-114058369-B | Fluorescent probe based on styryl oxazolone compound and biological application thereof | 中国科学院上海药物研究所 | 2024-07-02 | — | — | CN | disclosed |
| CN-113307772-B | Human plasma kallikrein inhibitors | 拜奥克里斯特制药公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-111315724-B | Organic film composition | 三星SDI株式会社 | 2024-06-07 | — | — | CN | disclosed |
| US-20240150295-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2024-05-09 | — | — | US | disclosed |
| US-20240150296-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2024-05-09 | — | — | US | disclosed |
| CN-112707908-B | Organic electronic material and application thereof | 北京鼎材科技有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-117624171-A | Organic electronic material and application thereof | 北京鼎材科技有限公司 | 2024-03-01 | — | — | CN | disclosed |
| WO-2024034311-A1 | SEMICONDUCTOR SUBSTRATE PRODUCTION METHOD AND FILM FORMING COMPOSITION | JSR株式会社 | 2024-02-15 | — | — | WO | disclosed |
| US-11810953-B2 | Sensor having graphene transistors | Graphenea Semiconductor SLU (ES) | 2023-11-07 | — | — | US | disclosed |
| CN-116813979-A | Nucleating agent, synthetic resin composition containing same, and molded article thereof | 株式会社ADEKA | 2023-09-29 | — | — | CN | disclosed |
| EP-4241073-A1 | SENSOR HAVING GRAPHENE TRANSISTORS | Graphenea Semiconductor SLU (ES) | 2023-09-13 | — | — | EP | disclosed |
| US-11708332-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708332-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708332-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708333-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708333-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708333-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-07-25 | — | — | US | disclosed |
| US-11685721-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-06-27 | — | — | US | disclosed |
| US-11685721-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-06-27 | — | — | US | disclosed |
| US-11685721-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2023-06-27 | — | — | US | disclosed |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNIV ARIZONA STATE (US) | 2023-06-22 | — | — | US | disclosed |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNIV ARIZONA STATE (US) | 2023-06-22 | — | — | US | disclosed |
| CN-112839988-B | Nucleating agent, synthetic resin composition containing same, and molded article thereof | 株式会社ADEKA | 2023-06-06 | — | — | CN | disclosed |
| EP-4180424-A1 | SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS | BioCryst Pharmaceuticals, Inc. (US) | 2023-05-17 | — | — | EP | disclosed |
| CN-110383173-B | Composition for forming resist underlayer film, method for forming resist underlayer film, and method for manufacturing patterned substrate | JSR株式会社 | 2023-05-09 | — | — | CN | disclosed |
| US-20230094305-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-03-30 | — | — | US | disclosed |
| US-20230100082-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-03-30 | — | — | US | disclosed |
| US-20230056538-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-02-23 | — | — | US | disclosed |
| US-20230056538-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2023-02-23 | — | — | US | disclosed |
| US-11569461-B2 | Organic electroluminescence device and organometallic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-31 | — | — | US | disclosed |
| CN-115304607-A | Process for preparing pyrazolopyrimidine derivatives | 华南农业大学 | 2022-11-08 | — | — | CN | disclosed |
| CN-113372238-B | Imine compound and its synthesis method and use | 上海科技大学 | 2022-09-23 | — | — | CN | disclosed |
| EP-3828173-B1 | SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS | BIOCRYST PHARM INC (US) | 2022-08-31 | — | — | EP | disclosed |
| US-11420991-B2 | Confined porphyrin Co(II) and preparation method and application thereof | ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) | 2022-08-23 | — | — | US | disclosed |
| WO-2022172551-A1 | LAMINATE, LAYER-FORMING COMPOSITION, LAYER, METHOD FOR MANUFACTURING LAMINATE, AND ELECTRONIC ELEMENT | JSR株式会社 | 2022-08-18 | — | — | WO | disclosed |
| WO-2022096640-A1 | SENSOR HAVING GRAPHENE TRANSISTORS | GRAPHENEA S.A (ES) | 2022-05-12 | — | — | WO | disclosed |
| US-20220136996-A1 | SENSOR HAVING GRAPHENE TRANSISTORS | Graphenea Semiconductor SLU (ES) | 2022-05-05 | — | — | US | disclosed |
| CN-114058369-A | Fluorescent probe based on styrene oxazolone compound and biological application thereof | 中国科学院上海药物研究所 | 2022-02-18 | — | — | CN | disclosed |
| US-11230530-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2022-01-25 | — | — | US | disclosed |
| US-11230530-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2022-01-25 | — | — | US | disclosed |
| US-20210403470-A1 | NOVEL METHODS FOR PREPARATION OF SUBSTITUTED PYRIDINES AND RELATED NOVEL COMPOUNDS | WATKINS EDMOND BLAKE (US) | 2021-12-30 | — | — | US | disclosed |
| US-20210403470-A1 | NOVEL METHODS FOR PREPARATION OF SUBSTITUTED PYRIDINES AND RELATED NOVEL COMPOUNDS | WATKINS EDMOND BLAKE (US) | 2021-12-30 | — | — | US | disclosed |
| US-20210401803-A1 | COMPOUNDS AND USES THEREOF | THE UNIVERSITY OF THE WEST INDIES (TT) | 2021-12-30 | — | — | US | disclosed |
| US-11203574-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-12-21 | — | — | US | disclosed |
| US-11203574-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-12-21 | — | — | US | disclosed |
| US-11192861-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-12-07 | — | — | US | disclosed |
| US-11192861-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2021-12-07 | — | — | US | disclosed |
| CN-112552305-B | Benzocyclohepta-imidazopyridine flame-retardant ultraviolet-resistant molecular material and preparation method and application thereof | 广东省测试分析研究所（中国广州分析测试中心） | 2021-11-30 | — | — | CN | disclosed |
| CN-109912576-B | Cyclic or spirocyclic diamine pyrimidine-hydroxamic acids and their use | 华东理工大学 | 2021-11-19 | — | — | CN | disclosed |
| US-11117893-B2 | Methods for preparation of substituted pyridines and related novel compounds | UNION UNIVERSITY (US) | 2021-09-14 | — | — | US | disclosed |
| US-11117893-B2 | Methods for preparation of substituted pyridines and related novel compounds | UNION UNIVERSITY (US) | 2021-09-14 | — | — | US | disclosed |
| CN-113372238-A | Imine compound and its synthesis method and use | 上海科技大学 | 2021-09-10 | — | — | CN | disclosed |
| CN-113307772-A | Human plasma kallikrein inhibitors | 拜奥克里斯特制药公司 | 2021-08-27 | — | — | CN | disclosed |
| CN-109810108-B | 2, 8-diaza-spiro- [4,5] -decane pyrimidine-hydroxamic acid compound and application thereof | 华东理工大学 | 2021-08-06 | — | — | CN | disclosed |
| EP-3828173-A1 | SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS | BioCryst Pharmaceuticals, Inc. (US) | 2021-06-02 | — | — | EP | disclosed |
| US-20210155650-A1 | CONFINED PORPHYRIN CO(II) AND PREPARATION METHOD AND APPLICATION THEREOF | ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) | 2021-05-27 | — | — | US | disclosed |
| EP-3062151-B1 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | MITSUBISHI GAS CHEMICAL CO (JP) | 2021-05-05 | — | — | EP | disclosed |
| CN-112707908-A | Organic electronic material and application thereof | 北京鼎材科技有限公司 | 2021-04-27 | — | — | CN | disclosed |
| CN-112552305-A | Novel benzocyclohepta-imidazopyridine flame-retardant ultraviolet-resistant molecular material and preparation method and application thereof | 广东省测试分析研究所（中国广州分析测试中心） | 2021-03-26 | — | — | CN | disclosed |
| US-20210078952-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2021-03-18 | — | — | US | disclosed |
| US-20210078952-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2021-03-18 | — | — | US | disclosed |
| US-20210047275-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2021-02-18 | — | — | US | disclosed |
| US-20210047275-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2021-02-18 | — | — | US | disclosed |
| US-20210047276-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2021-02-18 | — | — | US | disclosed |
| US-20210047276-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2021-02-18 | — | — | US | disclosed |
| CN-106257976-B | Human plasma kallikrein inhibitors | 拜奥克里斯特制药公司 | 2021-02-02 | — | — | CN | disclosed |
| US-20210024526-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | UNITED STATES DEPARTMENT OF ENERGY | 2021-01-28 | — | — | US | disclosed |
| US-10889554-B2 | Excimer forming compounds | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2021-01-12 | — | — | US | disclosed |
| CN-110938078-B | Limited porphyrin Co (II) and preparation method and application thereof | 浙江工业大学 | 2021-01-01 | — | — | CN | disclosed |
| CN-106458910-B | Mitochondrial aldehyde dehydrogenase 2(ALDH2) binding polycyclic amides and their use for treating cancer | 亚倍生技制药公司 | 2020-11-06 | — | — | CN | disclosed |
| EP-3113772-B1 | TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS | BIOCRYST PHARM INC (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-3113772-B1 | TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS | BIOCRYST PHARM INC (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-3107899-B1 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE 2 (ALDH2) BINDING POLYCYCLIC AMIDES AND THEIR USE FOR THE TREATMENT OF CANCER | AVIV THERAPEUTICS INC (US) | 2020-08-12 | — | — | EP | disclosed |
| CN-106957217-B | Polyhydric phenol compound for resist composition | 三菱瓦斯化学株式会社 | 2020-07-24 | — | — | CN | disclosed |
| US-10689346-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2020-06-23 | — | — | US | disclosed |
| US-10689346-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2020-06-23 | — | — | US | disclosed |
| CN-111315724-A | Monomer, polymer, organic film composition, and pattern forming method | 三星SDI株式会社 | 2020-06-19 | — | — | CN | disclosed |
| US-10633345-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2020-04-28 | — | — | US | disclosed |
| US-10633345-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2020-04-28 | — | — | US | disclosed |
| CN-110938078-A | Limited porphyrin Co (II) and preparation method and application thereof | 浙江工业大学 | 2020-03-31 | — | — | CN | disclosed |
| US-20200095245-A1 | NOVEL METHODS FOR PREPARATION OF SUBSTITUTED PYRIDINES AND RELATED NOVEL COMPOUNDS | UNION UNIVERSITY | 2020-03-26 | — | — | US | disclosed |
| US-20200095245-A1 | NOVEL METHODS FOR PREPARATION OF SUBSTITUTED PYRIDINES AND RELATED NOVEL COMPOUNDS | UNION UNIVERSITY | 2020-03-26 | — | — | US | disclosed |
| US-20190322626-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2019-10-24 | — | — | US | disclosed |
| US-20190322626-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2019-10-24 | — | — | US | disclosed |
| CN-106336372-B | Monomer, organic layer composition, organic layer and the method for forming pattern | 三星SDI株式会社 | 2019-09-24 | — | — | CN | disclosed |
| US-10392387-B2 | Substituted benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,8]naphthyridines, benzo[4,5]imidazo[1,2-a]phenanthro[9,10-c][1,5]naphthyridines and dibenzo[f,h]benzo[4,5]imidazo[2,1-a]pyrazino[2,3-c]isoquinolines as thermally assisted delayed fluorescent materials | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2019-08-27 | — | — | US | disclosed |
| US-10364221-B2 | Monomer, organic layer composition, organic layer, and method of forming patterns | SAMSUNG SDI CO., LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| US-10329260-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2019-06-25 | — | — | US | disclosed |
| US-10329260-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2019-06-25 | — | — | US | disclosed |
| US-20190181358-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LAPTO CO., LTD. (KR) | 2019-06-13 | — | — | US | disclosed |
| EP-2970124-B1 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF | UNIV LELAND STANFORD JUNIOR (US) | 2019-05-22 | — | — | EP | disclosed |
| US-10266565-B2 | Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2019-04-23 | — | — | US | disclosed |
| US-10227304-B2 | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2019-03-12 | — | — | US | disclosed |
| US-20180354906-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2018-12-13 | — | — | US | disclosed |
| US-10125102-B2 | Human plasma kallikrein inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2018-11-13 | — | — | US | disclosed |
| US-20180258049-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2018-09-13 | — | — | US | disclosed |
| CN-108349913-A | Compound and organic light emitting device including the same | 株式会社LG化学 | 2018-07-31 | — | — | CN | disclosed |
| CN-108349914-A | Organic light emitting device | 株式会社LG化学 | 2018-07-31 | — | — | CN | disclosed |
| US-9908831-B2 | Resist composition, method for forming resist pattern, polyphenolic compound for use in the composition, and alcoholic compound that can be derived therefrom | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-03-06 | — | — | US | disclosed |
| US-9879036-B2 | Mitochondrial aldehyde dehydrogenase-2 binding compounds and methods of use thereof | AVIV THERAPEUTICS, INC. (US) | 2018-01-30 | — | — | US | disclosed |
| CN-107413378-A | A kind of preparation method for the graphite phase carbon nitride visible light catalyst that combined polymerization is modified | 中国科学院上海硅酸盐研究所 | 2017-12-01 | — | — | CN | disclosed |
| CN-107400129-A | A kind of dibenzo benzimidizole derivatives and its application | 长春海谱润斯科技有限公司 | 2017-11-28 | — | — | CN | disclosed |
| EP-2794620-B1 | BODIPY STRUCTURE FLUORESCENCE PROBES FOR DIVERSE BIOLOGICAL APPLICATIONS | NAT UNIV SINGAPORE (SG) | 2017-11-15 | — | — | EP | disclosed |
| US-20170320828-A1 | Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2017-11-09 | — | — | US | disclosed |
| US-20170183279-A1 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | MITSUBISHI GAS CHEMICAL CO (JP) | 2017-06-29 | — | — | US | disclosed |
| US-9670162-B2 | Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIO (US) | 2017-06-06 | — | — | US | disclosed |
| CN-106674237-A | Preparation method of polycyclic aromatic hydrocarbon substituted porphyrin having strong two-photon absorption property | 济宁学院 | 2017-05-17 | — | — | CN | disclosed |
| CN-106573912-A | Triazine compound, method for producing same, and application for same | 东曹株式会社 | 2017-04-19 | — | — | CN | disclosed |
| EP-2743769-B1 | RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, POLYPHENOL COMPOUND USED THEREIN, AND ALCOHOL COMPOUND CAPABLE OF BEING DERIVED THEREFROM | MITSUBISHI GAS CHEMICAL CO (JP) | 2017-03-22 | — | — | EP | disclosed |
| US-9598392-B2 | Resist composition, method for forming resist pattern, polyphenolic compound for use in the composition, and alcoholic compound that can be derived therefrom | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2017-03-21 | — | — | US | disclosed |
| US-20170073314-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2017-03-16 | — | — | US | disclosed |
| US-20170073314-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2017-03-16 | — | — | US | disclosed |
| US-20170073314-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2017-03-16 | — | — | US | disclosed |
| US-20170057982-A1 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 BINDING COMPOUNDS AND METHODS OF USE THEREOF | AVIV THERAPEUTICS, INC. (US) | 2017-03-02 | — | — | US | disclosed |
| EP-2332905-B1 | BCRP/ABCG2 Inhibitor | YAKULT HONSHA KK (JP) | 2017-03-01 | — | — | EP | disclosed |
| CN-106336372-A | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | 三星SDI株式会社 | 2017-01-18 | — | — | CN | disclosed |
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | SAMSUNG SDI CO., LTD. (KR) | 2017-01-12 | — | — | US | disclosed |
| EP-3113772-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | Biocryst Pharmaceuticals, Inc. (US) | 2017-01-11 | — | — | EP | disclosed |
| US-9540339-B2 | Resist composition, method for forming resist pattern, polyphenolic compound for use in the composition, and alcoholic compound that can be derived therefrom | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2017-01-10 | — | — | US | disclosed |
| EP-3107899-A1 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE 2 (ALDH2) BINDING POLYCYCLIC AMIDES AND THEIR USE FOR THE TREATMENT OF CANCER | Aldea Pharmaceuticals, Inc. (US) | 2016-12-28 | — | — | EP | disclosed |
| CN-106257976-A | Human plasma kallikrein inhibitors | 拜奥克里斯特制药公司 | 2016-12-28 | — | — | CN | disclosed |
| US-9523031-B2 | Organic electroluminescent device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-20 | — | — | US | disclosed |
| US-9523031-B2 | Organic electroluminescent device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-20 | — | — | US | disclosed |
| US-20160304473-A1 | EXCIMER FORMING COMPOUNDS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-10-20 | — | — | US | disclosed |
| US-20160304473-A1 | EXCIMER FORMING COMPOUNDS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-10-20 | — | — | US | disclosed |
| EP-3062151-A1 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-08-31 | — | — | EP | disclosed |
| US-9423396-B2 | Bodipy structure fluorescence probes for diverse biological applications | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2016-08-23 | — | — | US | disclosed |
| US-9423396-B2 | Bodipy structure fluorescence probes for diverse biological applications | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2016-08-23 | — | — | US | disclosed |
| EP-3051350-A2 | ALCOHOLIC COMPOUND AND METHOD FOR PRODUCING ALCOHOLIC COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-08-03 | — | — | EP | disclosed |
| US-20160176840-A1 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-06-23 | — | — | US | disclosed |
| US-9370506-B2 | Modulators of aldehyde dehydrogenase and methods of use thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2016-06-21 | — | — | US | disclosed |
| US-20160145231-A1 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-05-26 | — | — | US | disclosed |
| US-9345693-B2 | Modulators of aldehyde dehydrogenase activity and methods of use thereof | The Board of Trustees-Leland Stanford Junior University (US) | 2016-05-24 | — | — | US | disclosed |
| CN-102209541-B | Modulators of aldehyde dehydrogenase activity and its using method | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2016-05-18 | — | — | CN | disclosed |
| US-20160107996-A1 | Mitochondrial Aldehyde Dehyrogenase-2 Modulators and Methods of Use Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2016-04-21 | — | — | US | disclosed |
| US-9316913-B2 | Underlayer film-forming material for lithography, underlayer film for lithography, and pattern formation method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2016-04-19 | — | — | US | disclosed |
| US-9315484-B2 | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof | The Board of Trustees—Leland Stanford Junior University (US) | 2016-04-19 | — | — | US | disclosed |
| US-9273025-B2 | — | — | 2016-03-01 | — | — | US | disclosed |
| CN-105358531-A | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof | UNIV LELAND STANFORD JUNIOR | 2016-02-24 | — | — | CN | disclosed |
| EP-2970124-A2 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF | The Board of Trustees of the Leland Stanford Junior University (US) | 2016-01-20 | — | — | EP | disclosed |
| CN-101669030-B | Mitochondrial aldehyde dehydrogenase-2 modulators and its using method | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2016-01-13 | — | — | CN | disclosed |
| EP-2743770-B1 | UNDERLAYER FILM-FORMING MATERIAL FOR LITHOGRAPHY, UNDERLAYER FILM FOR LITHOGRAPHY, AND PATTERN FORMATION METHOD | MITSUBISHI GAS CHEMICAL CO (JP) | 2015-12-30 | — | — | EP | disclosed |
| WO-2015199141-A1 | COUMALIN-BASED CONDENSED RING COMPOUND EXHIBITING LUMINESCENCE/SEMICONDUCTOR PROPERTIES, AND METHOD FOR MANUFACTURING SAME | 国立大学法人 群馬大学 | 2015-12-30 | — | — | WO | disclosed |
| EP-2126574-B1 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF | UNIV LELAND STANFORD JUNIOR (US) | 2015-12-23 | — | — | EP | disclosed |
| US-9175038-B2 | Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2015-11-03 | — | — | US | disclosed |
| US-9175038-B2 | Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2015-11-03 | — | — | US | disclosed |
| EP-2937341-A1 | 4-(BENZYL)-PIPERAZINE-1-CARBOXYLIC ACID PHENYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF FATTY ACID AMIDE HYDROLASE (FAAH) FOR THE TREATMENT OF ANXIETY, PAIN AND OTHER CONDITIONS | Janssen Pharmaceutica N.V. (BE) | 2015-10-28 | — | — | EP | disclosed |
| US-9169224-B2 | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase | JANSSEN PHARMACEUTICA NV (BE) | 2015-10-27 | — | — | US | disclosed |
| WO-2015134998-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 2015-09-11 | — | — | WO | disclosed |
| WO-2015134998-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 2015-09-11 | — | — | WO | disclosed |
| WO-2015127137-A1 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE 2 (ALDH2) BINDING POLYCYCLIC AMIDES AND THEIR USE FOR THE TREATMENT OF CANCER | ALDEA PHARMACEUTICALS, INC. (US) | 2015-08-27 | — | — | WO | disclosed |
| US-9102651-B2 | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof | The Board of Trustees-Leland Stanford Junior University (US) | 2015-08-11 | — | — | US | disclosed |
| US-20150182511-A1 | MODULATORS OF ALDEHYDE DEHYDROGENASE ACTIVITY AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2015-07-02 | — | — | US | disclosed |
| US-20150182506-A1 | Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2015-07-02 | — | — | US | disclosed |
| WO-2015089639-A1 | EXCIMER FORMING COMPOUNDS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2015-06-25 | — | — | WO | disclosed |
| EP-1836179-B1 | PIPERIDINE- AND PIPERAZINE-1-CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF FATTY ACID AMIDE HYDROLASE (FAAH) FOR THE TREATMENT OF ANXIETY, PAIN AND OTHER CONDITIONS | JANSSEN PHARMACEUTICA NV (BE) | 2015-05-06 | — | — | EP | disclosed |
| US-9018409-B2 | Process for functionalization of unsaturated compounds | MEURICE R&D ASBL (BE) | 2015-04-28 | — | — | US | disclosed |
| US-20150105456-A1 | Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2015-04-16 | — | — | US | disclosed |
| US-20150090691-A1 | MATERIAL FOR FORMING UNDERLAYER FILM LITHOGRAPHY, UNDERLAYER FILM FOR LITHOGRAPHY AND PATTERN FORMING METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2015-04-02 | — | — | US | disclosed |
| EP-1820801-B1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORP (JP) | 2015-04-01 | — | — | EP | disclosed |
| US-8906942-B2 | Modulators of aldhehyde dehydrogenase activity and methods of use thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-12-09 | — | — | US | disclosed |
| US-20140359794-A1 | BODIPY STRUCTURE FLUORESCENCE PROBES FOR DIVERSE BIOLOGICAL APPLICATIONS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2014-12-04 | — | — | US | disclosed |
| US-20140359794-A1 | BODIPY STRUCTURE FLUORESCENCE PROBES FOR DIVERSE BIOLOGICAL APPLICATIONS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2014-12-04 | — | — | US | disclosed |
| US-20140343045-A1 | Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-11-20 | — | — | US | disclosed |
| WO-2014160185-A2 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20140248561-A1 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-09-04 | — | — | US | disclosed |
| US-8772295-B2 | Modulators of aldehyde dehydrogenase and methods of use thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-07-08 | — | — | US | disclosed |
| EP-2743769-A1 | RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, POLYPHENOL COMPOUND USED THEREIN, AND ALCOHOL COMPOUND CAPABLE OF BEING DERIVED THEREFROM | Mitsubishi Gas Chemical Company, Inc. (JP) | 2014-06-18 | — | — | EP | disclosed |
| EP-2743770-A1 | UNDERLAYER FILM-FORMING MATERIAL FOR LITHOGRAPHY, UNDERLAYER FILM FOR LITHOGRAPHY, AND PATTERN FORMATION METHOD | Mitsubishi Gas Chemical Company, Inc. (JP) | 2014-06-18 | — | — | EP | disclosed |
| US-20140142044-A1 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | The United States of America, as represented by the Secretary, Department of Health & Human Servic (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140142044-A1 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | The United States of America, as represented by the Secretary, Department of Health & Human Servic (US) | 2014-05-22 | — | — | US | disclosed |
| US-8697742-B2 | BCRP/ABCG2 inhibitor | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2014-04-15 | — | — | US | disclosed |
| US-20130331396-A1 | PIPERAZINYL AND PIPERIDINYL UREAS AS MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA NV (US) | 2013-12-12 | — | — | US | disclosed |
| US-20130267501-A1 | Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-10-10 | — | — | US | disclosed |
| US-20130253010-A1 | Modulators of Aldhehyde Dehydrogenase Activity and Methods of Use Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-09-26 | — | — | US | disclosed |
| US-8530476-B2 | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase | JANSSEN PHARMACEUTICA NV (BE) | 2013-09-10 | — | — | US | disclosed |
| EP-2632886-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | Meurice R&D ASBL (BE) | 2013-09-04 | — | — | EP | disclosed |
| US-20130211033-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | MEURICE R&D ASBL (BE) | 2013-08-15 | — | — | US | disclosed |
| US-8486959-B2 | Dibenzo[f,h]isoquinoline derivatives | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2013-07-16 | — | — | US | disclosed |
| WO-2013095305-A1 | BODIPY STRUCTURE FLUORESCENCE PROBES FOR DIVERSE BIOLOGICAL APPLICATIONS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2013-06-27 | — | — | WO | disclosed |
| CN-101146786-B | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase | JANSSEN PHARMACEUTICA NV | 2013-03-27 | — | — | CN | disclosed |
| US-8389522-B2 | Modulators of aldehyde dehydrogenase and methods of use thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-03-05 | — | — | US | disclosed |
| US-8354435-B2 | Modulators of aldehyde dehydrogenase activity and methods of use thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-01-15 | — | — | US | disclosed |
| CN-101166719-B | Bcrp/abcg2 inhibitor | YAKULT HONSHA KK | 2012-11-07 | — | — | CN | disclosed |
| WO-2012142245-A2 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | THE GOVERNMENT OF THE UNITED OF AMERIA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2012-10-18 | — | — | WO | disclosed |
| CN-102597091-A | Flame retardant expandable polymers | SUNPOR KUNSTSTOFF GMBH | 2012-07-18 | — | — | CN | disclosed |
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178215-B2 | Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound | PIONEER CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| WO-2012055946-A1 | PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS | MEURICE R&D ASBL (BE) | 2012-05-03 | — | — | WO | disclosed |
| US-20120065146-A1 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120065146-A1 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120010248-A1 | Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-01-12 | — | — | US | disclosed |
| US-8048317-B2 | Generation of free radicals, analytical methods, bacterial disinfections, and oxidative destruction of organic chemicals using zero valent iron and other metals | UNIVERSITY OF HAWAII (US) | 2011-11-01 | — | — | US | disclosed |
| CN-102209541-A | Modulators of aldehyde dehydrogenase activity and methods of use thereof | UNIV LELAND STANFORD JUNIOR | 2011-10-05 | — | — | CN | disclosed |
| CN-102202669-A | Aldehyde dehydrogenase modulators and methods of use thereof | UNIV LELAND STANFORD JUNIOR | 2011-09-28 | — | — | CN | disclosed |
| EP-2349279-A1 | MODULATORS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF | The Board of Trustees of The Leland Stanford Junior University (US) | 2011-08-03 | — | — | EP | disclosed |
| US-20110172261-A1 | DIBENZO[f,h]ISOQUINOLINE DERIVATIVES | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2011-07-14 | — | — | US | disclosed |
| EP-2337563-A1 | MODULATORS OF ALDEHYDE DEHYDROGENASE ACTIVITY AND METHODS OF USE THEREOF | The Board of Trustees of The Leland Stanford Junior University (US) | 2011-06-29 | — | — | EP | disclosed |
| EP-2332905-A1 | BCRP/ABCG3 Inhibitor | Kabushiki Kaisha Yakult Honsha (JP) | 2011-06-15 | — | — | EP | disclosed |
| US-20110105602-A2 | Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-05-05 | — | — | US | disclosed |
| WO-2010132869-A2 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | GOVERNMENT OF THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2010-11-18 | — | — | WO | disclosed |
| US-7829257-B2 | Photosensitive resin composition | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-11-09 | — | — | US | disclosed |
| US-7790896-B2 | RNA-selective probes for live cell imaging of nuclear structure and function | NEW YORK UNIVERSITY (US) | 2010-09-07 | — | — | US | disclosed |
| US-7790896-B2 | RNA-selective probes for live cell imaging of nuclear structure and function | NEW YORK UNIVERSITY (US) | 2010-09-07 | — | — | US | disclosed |
| US-7759459-B2 | Fluorescent assays for protein kinases | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2010-07-20 | — | — | US | disclosed |
| WO-2010062308-A1 | MODULATORS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-06-03 | — | — | WO | disclosed |
| US-20100113423-A1 | Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2010-05-06 | — | — | US | disclosed |
| WO-2010028175-A1 | MODULATORS OF ALDEHYDE DEHYDROGENASE ACTIVITY AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-03-11 | — | — | WO | disclosed |
| US-20100063100-A1 | MODULATORS OF ALDEHYDE DEHYDROGENASE ACTIVITY AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-03-11 | — | — | US | disclosed |
| CN-101669030-A | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof | UNIV LELAND STANFORD JUNIOR | 2010-03-10 | — | — | CN | disclosed |
| US-20100004261-A1 | PIPERAZINYL AND PIPERIDINYL UREAS AS MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA NV (BE) | 2010-01-07 | — | — | US | disclosed |
| EP-2126574-A2 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF | The Board of Trustees of The Leland Stanford Junior University (US) | 2009-12-02 | — | — | EP | disclosed |
| US-20090253656-A1 | BCRP/ABCG2 INHIBITOR | KABUSHIKI KAISHA YAKULT HONSHA (JP) | 2009-10-08 | — | — | US | disclosed |
| US-7598249-B2 | 4-(3,4-dibromo-benzyl)-piperazine-1-carboxylic acid pyridin-3-ylamide; fatty acid amide hydrolase (FAAH) activity; anxiety, pain, inflammation, sleep disorders, eating disorders, or movement disorders such as multiple sclerosis | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-10-06 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
| US-20090236973-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | PIONEER CORPORATION (JO) | 2009-09-24 | — | — | US | disclosed |
| CN-100526328-C | 17 beta-hydroxysteroid dehydrogenase inhibitors | STERIX LTD (GB) | 2009-08-12 | — | — | CN | disclosed |
| US-20090082431-A1 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-03-26 | — | — | US | disclosed |
| US-7446135-B2 | Block copolymeric dispersant for pigment particle in aqueous system, and ink composition comprising the same | SAMSUNG ELECTRONCIS CO., LTD. (KR) | 2008-11-04 | — | — | US | disclosed |
| WO-2008112164-A2 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2008-09-18 | — | — | WO | disclosed |
| US-7384388-B2 | Styryl dyes with linker | NEW YORK UNIVERSITY (US) | 2008-06-10 | — | — | US | disclosed |
| US-7384388-B2 | Styryl dyes with linker | NEW YORK UNIVERSITY (US) | 2008-06-10 | — | — | US | disclosed |
| CN-101166719-A | BCRP/ABCG2 Inhibitors | YAKULT HONSHA KK (JP) | 2008-04-23 | — | — | CN | disclosed |
| US-20080064037-A1 | RNA-SELECTIVE PROBES FOR LIVE CELL IMAGING OF NUCLEAR STRUCTURE AND FUNCTION | NEW YORK UNIVERSITY (US) | 2008-03-13 | — | — | US | disclosed |
| US-20080064037-A1 | RNA-SELECTIVE PROBES FOR LIVE CELL IMAGING OF NUCLEAR STRUCTURE AND FUNCTION | NEW YORK UNIVERSITY (US) | 2008-03-13 | — | — | US | disclosed |
| EP-1864972-A1 | BCRP/ABCG2 INHIBITOR | Kabushiki Kaisha Yakult Honsha (JP) | 2007-12-12 | — | — | EP | disclosed |
| US-20070224448-A1 | Organic Electroluminescent Device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070224448-A1 | Organic Electroluminescent Device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1836179-A1 | PIPERAZINYL AND PIPERIDINYL UREAS AS MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-09-26 | — | — | EP | disclosed |
| CN-100339427-C | Block copolymeric dispersant for pigment particle in aqueous system, and ink composition comprising the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-09-26 | — | — | CN | disclosed |
| EP-1820801-A1 | ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT | Pioneer Corporation (JP) | 2007-08-22 | — | — | EP | disclosed |
| WO-2006065825-A9 | GENERATION OF FREE RADICALS, ANALYTICAL METHODS, BACTERIAL DISINFECTIONS, AND OXIDATIVE DESTRUCTION OF ORGANIC CHEMICALS USING ZERO VALENT IRON AND OTHER METALS | UNIV HAWAII (US) | 2006-08-10 | — | — | WO | disclosed |
| US-20060175266-A1 | Generation of free radicals, analytical methods, bacterial disinfections, and oxidative destruction of organic chemicals using zero valent iron and other metals | HAWAII, UNIVERSITY OF | 2006-08-10 | — | — | US | disclosed |
| US-20060173184-A1 | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-08-03 | — | — | US | disclosed |
| WO-2006074025-A1 | PIPERAZINYL AND PIPERIDINYL UREAS AS MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-07-13 | — | — | WO | disclosed |
| WO-2006065825-A2 | GENERATION OF FREE RADICALS, ANALYTICAL METHODS, BACTERIAL DISINFECTIONS, AND OXIDATIVE DESTRUCTION OF ORGANIC CHEMICALS USING ZERO VALENT IRON AND OTHER METALS | UNIVERSITY OF HAWAII (US) | 2006-06-22 | — | — | WO | disclosed |
| CN-1791611-A | 17beta-hydroxysteroid dehydrogenase inhibitors. | STERIX LTD (GB) | 2006-06-21 | — | — | CN | disclosed |
| CN-1765866-A | 1,3-dichlor-6-trifluomethyl-9-phenanthrene formaldehyde preparation method | ZHEJIANG NHU CO LTD (CN) | 2006-05-03 | — | — | CN | disclosed |
| CN-1222525-C | Bicyclic imidazol-3-ylamine derivatives substituted on a six-membered ring | GRUENENTHAL GMBH (DE) | 2005-10-12 | — | — | CN | disclosed |
| US-6942966-B1 | libraries formed by permutations; combinatorial chemistry; drug screening | ISIS PHARMACEUTICALS, INC. (US) | 2005-09-13 | — | — | US | disclosed |
| CN-1654115-A | Block copolymeric dispersant for pigment particle in aqueous system, and ink composition comprising the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2005-08-17 | — | — | CN | disclosed |
| US-20050132931-A1 | Block copolymeric dispersant for pigment particle in aqueous system, and ink composition comprising the same | SAMSUNG ELECTRONICS CO., LTD. | 2005-06-23 | — | — | US | disclosed |
| US-20050130941-A1 | Methods of treating alzheimer's disease | PHARMACIA & UPJOHN COMPANY LLC | 2005-06-16 | — | — | US | disclosed |
| US-6867218-B2 | Compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2005-03-15 | — | — | US | disclosed |
| US-20050054024-A1 | Fluorescent assays for protein kinases | NATIONAL INSTITUTES OF HEALTH | 2005-03-10 | — | — | US | disclosed |
| US-6849642-B2 | Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ring | GRUENENTHAL GMBH (DE) | 2005-02-01 | — | — | US | disclosed |
| US-6828427-B1 | Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same | ISIS PHARMACEUTICALS, INC. | 2004-12-07 | — | — | US | disclosed |
| US-6750344-B1 | MONOCYCLIC AMINE SCAFFOLD BEARING AT LEAST TWO SITES OF DIVERSITY, CYCLIZED TO FORM BICYCLIC AMINE SCAFFOLDS; 7-AMINO-PYRROLO(1,2-A)PYRAZIN-4-ONE COMPOUNDS | ISIS PHARMACEUTICALS, INC. | 2004-06-15 | — | — | US | disclosed |
| US-6706767-B2 | MULTIPLE SCLEROSIS; RHEUMATIC DISEASES; SKIN DISORDERS | CHEMOKINE THERAPEUTICS CORPORATION (CA) | 2004-03-16 | — | — | US | disclosed |
| EP-1392315-A1 | METHODS OF TREATING ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-03-03 | — | — | EP | disclosed |
| US-20030195200-A1 | Compounds, their preparation and use | VTVX HOLDINGS II LLC | 2003-10-16 | — | — | US | disclosed |
| US-6559303-B1 | Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical | ISIS PHARMACEUTICALS, INC. | 2003-05-06 | — | — | US | disclosed |
| US-6555577-B1 | For treatment and/or prevention of conditions mediated by the Peroxisome Proliferator-Activated Receptors (PPAR), such as diabetes and/or obesity; 3-(4-(3-Biphenyl-4-yl-but-2-enyloxy)-phenyl)-2-butoxy-propionic acid for example | NOVO NORDISK A/S (DE) | 2003-04-29 | — | — | US | disclosed |
| US-20030069265-A1 | Therapeutics for chemokine mediated diseases | CHEMOKINE THERAPEUTICS CORPORATION (CA) | 2003-04-10 | — | — | US | disclosed |
| CN-1402727-A | Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring | GRUENENTHAL GMBH (DE) | 2003-03-12 | — | — | CN | disclosed |
| CN-1396903-A | novel compounds, their preparation and use | NOVO NORDISK AS (DK) | 2003-02-12 | — | — | CN | disclosed |
| WO-2002100410-A1 | METHODS OF TREATING ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2002-12-19 | — | — | WO | disclosed |
| EP-0752813-B1 | INHIBITORS OF METAZOAN PARASITE PROTEASES | UNIV CALIFORNIA (US) | 2002-12-11 | — | — | EP | disclosed |
| US-20020183327-A1 | Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ring | GRUENENTHAL GMBH. | 2002-12-05 | — | — | US | disclosed |
| EP-1254101-A1 | PROPIONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF DIABETES AND OBESITY | Novo Nordisk A/S (DK) | 2002-11-06 | — | — | EP | disclosed |
| WO-2002045702-A2 | TRICYCLIC THERAPEUTICS FOR CHEMOKINE MEDIATED DISEASES | CHEMOKINE THERAPEUTICS CORPORATION (CA) | 2002-06-13 | — | — | WO | disclosed |
| EP-1189891-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION Bioscience AG (DE) | 2002-03-27 | — | — | EP | disclosed |
| US-6362342-B1 | BIOSYNTHESIS; DRUG LIBRARIES | LION BIOSCIENCE AG (DE) | 2002-03-26 | — | — | US | disclosed |
| US-20020020832-A1 | Photosensitive resin composition | CIBA SPECIALTY CHEMICALS CORP. | 2002-02-21 | — | — | US | disclosed |
| US-6329523-B1 | FOR ANTIBACTERIAL PHARMACEUTICAL USE, USEFUL FOR IDENTIFYING METAL CHELATING SPECIES FOR ?HEAVY METAL? THERAPY; IMAGING AGENTS | ISIS PHARMACEUTICALS, INC. | 2001-12-11 | — | — | US | disclosed |
| US-6316626-B1 | Amine compounds and combinatorial libraries comprising same | ISIS PHARMACEUTICALS, INC. | 2001-11-13 | — | — | US | disclosed |
| EP-0872903-B1 | Method for making hydrogen storage alloy powder and electrode comprising the alloy powder | SHINETSU CHEMICAL CO (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-6277519-B1 | QUENCHING AN ALLOY MELT; COMMINUTION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-08-21 | — | — | US | disclosed |
| WO-2001055085-A1 | PROPIONIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF DIABETES AND OBESITY | NOVO NORDISK A/S (DK) | 2001-08-02 | — | — | WO | disclosed |
| US-6207826-B1 | Macrocyclic compounds having nitrogen-containing linkages | ISIS PHARMACEUTICALS, INC. | 2001-03-27 | — | — | US | disclosed |
| US-6197965-B1 | POLYARYLALKYLAMINO-SUBSTITUED PYRIDINE DERIVATIVES; DRUGS, MEDICINE, DIAGNOSTICS | ISIS PHARMACEUTICALS, INC. | 2001-03-06 | — | — | US | disclosed |
| US-6184389-B1 | FEATURE A PLURALITY OF FUNCTIONAL GROUPS ATTACHED TO BACKBONE AND PHOSPHORAMIDATE SITES | ISIS PHARMACEUTICALS, INC. | 2001-02-06 | — | — | US | disclosed |
| WO-2001000594-A1 | TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2001-01-04 | — | — | WO | disclosed |
| EP-0817787-A4 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS INC (US) | 2000-09-13 | — | — | EP | disclosed |
| US-6096144-A | TREATING WITH ACIDIC OR ALKALINE SOLUTION OF CONJUGATED UNSATURATED COMPOUND WITH AT LEAST 5 BONDS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-08-01 | — | — | US | disclosed |
| WO-1999050244-A9 | NITROXIDE FREE RADICAL DUAL INDICATOR AGENTS | LIPITEK INC (US) | 1999-12-09 | — | — | WO | disclosed |
| WO-1999050244-A1 | NITROXIDE FREE RADICAL DUAL INDICATOR AGENTS | LIPITEK, INC. (US) | 1999-10-07 | — | — | WO | disclosed |
| WO-1999012034-A1 | AMINE COMPOUNDS AND COMBINATORIAL LIBRARIES COMPRISING SAME | ISIS PHARMACEUTICALS, INC. (US) | 1999-03-11 | — | — | WO | disclosed |
| US-5858571-A | TREATING A PULVERIZED HYDROGEN ABSORBING ALLOY WITH A SOLUTION COMPRISING A CONJUGATED UNSATURATED COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0865439-A4 | COMBINATORIAL LIBRARIES HAVING AMINODIOL MONOMER SUBUNITS | ISIS PHARMACEUTICALS INC (US) | 1998-11-11 | — | — | EP | disclosed |
| EP-0872903-A1 | Method for making hydrogen storage alloy powder and electrode comprising the alloy powder | Shin-Etsu Chemical Co., Ltd. (JP) | 1998-10-21 | — | — | EP | disclosed |
| EP-0865439-A1 | COMBINATORIAL LIBRARIES HAVING AMINODIOL MONOMER SUBUNITS | ISIS PHARMACEUTICALS, INC. (US) | 1998-09-23 | — | — | EP | disclosed |
| US-5780250-A | Immunoassay standards for polyaromatic hydrocarbon detection | STRATEGIC DIAGNOSTICS, INC. (US) | 1998-07-14 | — | — | US | disclosed |
| US-5760048-A | TREATMENT OF STROKE AND NERVOUS SYSTEM DISORDERS | WARNER-LAMBERT COMPANY (US) | 1998-06-02 | — | — | US | disclosed |
| US-5753652-A | Antiretroviral hydrazine derivatives | NOVARTIS CORPORATION (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0817787-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1997031267-A1 | IMMUNOASSAY STANDARDS FOR POLYAROMATIC HYDROCARBON DETECTION | STRATEGIC DIAGNOSTICS, INC. (US) | 1997-08-28 | — | — | WO | disclosed |
| EP-0752813-A4 | INHIBITORS OF METAZOAN PARASITE PROTEASES | UNIV CALIFORNIA (US) | 1997-08-20 | — | — | EP | disclosed |
| US-5610192-A | Inhibitors of metazoan parasite proteases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-03-11 | — | — | US | disclosed |
| EP-0752813-A1 | INHIBITORS OF METAZOAN PARASITE PROTEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-01-15 | — | — | EP | disclosed |
| WO-1996040672-A1 | COMBINATORIAL LIBRARIES HAVING AMINODIOL MONOMER SUBUNITS | ISIS PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996030377-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-03 | — | — | WO | disclosed |
| EP-0521827-B1 | Pharmacological active hydrazin derivatives and process for their preparation | CIBA GEIGY AG (CH) | 1996-09-25 | — | — | EP | disclosed |
| EP-0604368-B1 | Anti retroviral hydrazine derivatives | CIBA GEIGY AG (CH) | 1996-09-18 | — | — | EP | disclosed |
| US-5554767-A | NERVOUS SYSTEM, CARDIOVASCULAR, AND BRAIN DISORDERS | WARNER-LAMBERT COMPANY (US) | 1996-09-10 | — | — | US | disclosed |
| EP-0548799-B1 | Diene polymers and copolymers terminated by reaction with fused-ring polynuclear aromatic compounds | BRIDGESTONE FIRESTONE INC (US) | 1996-05-01 | — | — | EP | disclosed |
| EP-0543305-B1 | Diene polymers having reduced hysteresis and improved raw viscosity incorporating primary partial coupling and terminals formed from fused-ring polynuclear aromatic compounds or aromatic nitrile compounds | BRIDGESTONE CORP (JP) | 1995-10-11 | — | — | EP | disclosed |
| US-5334665-A | Dispersant for carbon black, graphite; flow control agents | BRIDGESTONE/FIRESTONE, INC. (US) | 1994-08-02 | — | — | US | disclosed |
| EP-0604368-A1 | Anti retroviral hydrazine derivatives | CIBA-GEIGY AG (CH) | 1994-06-29 | — | — | EP | disclosed |
| WO-1994006280-A1 | INHIBITORS OF METAZOAN PARASITE PROTEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-03-31 | — | — | WO | disclosed |
| EP-0548799-A1 | Diene polymers and copolymers terminated by reaction with fused-ring polynuclear aromatic compounds | BRIDGESTONE/FIRESTONE, INC. (US) | 1993-06-30 | — | — | EP | disclosed |
| EP-0543305-A1 | Diene polymers having reduced hysteresis and improved raw viscosity incorporating primary partial coupling and terminals formed from fused-ring polynuclear aromatic compounds or aromatic nitrile compounds | BRIDGESTONE CORPORATION (JP) | 1993-05-26 | — | — | EP | disclosed |
| US-5210144-A | Polymers for tire tread | BRIDGESTONE CORPORATION (JP) | 1993-05-11 | — | — | US | disclosed |
| US-5210145-A | Tires, reduced rolling resistance | BRIDGESTONE/FIRESTONE, INC. (US) | 1993-05-11 | — | — | US | disclosed |
| EP-0527181-A4 | HETEROCYCLICETHENEDIYL COMPOUNDS WHICH INHIBIT EGF RECEPTOR TYROSINE KINASE | — | 1993-04-07 | — | — | EP | disclosed |
| US-5196446-A | Treatment of psoriasis, atherosclerosis | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1993-03-23 | — | — | US | disclosed |
| EP-0527181-A1 | HETEROCYCLICETHENEDIYL COMPOUNDS WHICH INHIBIT EGF RECEPTOR TYROSINE KINASE | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1993-02-17 | — | — | EP | disclosed |
| EP-0521827-A1 | Pharmacological active hydrazin derivatives and process for their preparation | CIBA-GEIGY AG (CH) | 1993-01-07 | — | — | EP | disclosed |
| US-5175302-A | Nucleophilic fluoroalkylation of aldehydes | ETHYL CORPORATION (US) | 1992-12-29 | — | — | US | disclosed |
| WO-1991016305-A1 | HETEROCYCLICETHENEDIYL COMPOUNDS WHICH INHIBIT EGF RECEPTOR TYROSINE KINASE | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1991-10-31 | — | — | WO | disclosed |
| JP-H03127791-A | PORPHYRIN COMPOUND AND OPTICAL RECORDING MATERIAL USING SAME | IDEMITSU KOSAN CO LTD | 1991-05-30 | — | — | JP | disclosed |
| US-4999429-A | Process for the preparation of α,α,β-1-trifluoro-1-olefinic derivatives | ETHYL CORPORATION (US) | 1991-03-12 | — | — | US | disclosed |
| EP-0405506-A1 | Tetrapeptide type-B CCK receptor ligands | ABBOTT LABORATORIES (US) | 1991-01-02 | — | — | EP | disclosed |
| EP-0199151-B1 | LIPOXYGENASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1990-11-07 | — | — | EP | disclosed |
| US-4931591-A | Novel 5-amino-4-hydroxyvaleryl derivatives | CIBA-GEIGY CORPORATION (US) | 1990-06-05 | — | — | US | disclosed |
| US-4902627-A | Method for detecting amine-containing drugs in body fluids by sims | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1990-02-20 | — | — | US | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4837327-A | Process for nucleophilic fluoroalkylation of aldehydes | ETHYL CORPORATION (US) | 1989-06-06 | — | — | US | disclosed |
| US-4808625-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1989-02-28 | — | — | US | disclosed |
| EP-0125701-B1 | POLYCYCLIC AROMATIC COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-08-03 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| US-4727060-A | HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1988-02-23 | — | — | US | disclosed |
| US-4719055-A | ANTITUMOR | BURROUGHS WELLCOME CO. (US) | 1988-01-12 | — | — | US | disclosed |
| US-4623661-A | HYDROXAMIC ACID DERIVATIVES | ABBOTT LABORATORIES (US) | 1986-11-18 | — | — | US | disclosed |
| EP-0199151-A2 | Lipoxygenase inhibiting compounds | ABBOTT LABORATORIES (US) | 1986-10-29 | — | — | EP | disclosed |
| EP-0096647-B1 | A METHOD FOR PREPARING A POLYMER CONTAINING PENDANT UNSATURATION | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1986-10-29 | — | — | EP | disclosed |
| EP-0184550-A2 | 5-Amino-4-hydroxy valeryl amide derivatives | CIBA-GEIGY AG (CH) | 1986-06-11 | — | — | EP | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| EP-0041675-B1 | 4-HALOGEN-5-(TRICHLOROMETHYL-PHENYL)-OXAZOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND RADIATION-SENSITIVE COMPOSITIONS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-12-11 | — | — | EP | disclosed |
| US-4511582-A | 2-METHYL-2-/PHENANTHRYLMETHYL/AMINOPROPANEDIOL OR ESTERS | BURROUGHS WELLCOME CO. (US) | 1985-04-16 | — | — | US | disclosed |
| EP-0125701-A2 | Polycyclic aromatic compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-11-21 | — | — | EP | disclosed |
| US-4446284-A | Method for preparing a polymer containing pendant unsaturation | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1984-05-01 | — | — | US | disclosed |
| US-4380629-A | Styryl-like compounds showing a color-developing and bleaching behavior with improved stability and prolonged lifetime | MATSUSHITA ELECTRIC INDUSTRIAL COMPANY, LIMITED (JP) | 1983-04-19 | — | — | US | disclosed |
| US-4371607-A | 4-Halogeno-5-(halogenomethyl-phenyl)-oxazole derivatives, a process for the preparation thereof, and radiation-sensitive compositions containing these derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-02-01 | — | — | US | disclosed |
| US-4340624-A | STYRYL-LIKE COMPOUNDS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1982-07-20 | — | — | US | disclosed |
| US-4314058-A | Indolins styryl-like compounds | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1982-02-02 | — | — | US | disclosed |
| EP-0041675-A2 | 4-Halogen-5-(trichloromethyl-phenyl)-oxazole derivatives, process for preparing them and radiation-sensitive compositions containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-12-16 | — | — | EP | disclosed |
| US-4147862-A | Method of preparing styryl-like compounds | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1979-04-03 | — | — | US | disclosed |
| US-4139274-A | Apparatus for changing color | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1979-02-13 | — | — | US | disclosed |
| US-4060677-A | Process for molecular weight lowering of vinyl halide polymers employing saturated carbon to carbon bonded aldehydes | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1977-11-29 | — | — | US | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-4003633-A | Color display device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JA) | 1977-01-18 | — | — | US | disclosed |
| US-4003633-A | Color display device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JA) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105456-A1 | Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof | ALDH2, ALDH5A1, AK2 | ERN1 4380/4885MAOB 492/4885TRPM4 1641/4885 |
| US-20080064037-A1 | RNA-SELECTIVE PROBES FOR LIVE CELL IMAGING OF NUCLEAR STRUCTURE AND FUNCTION | SNRPE, HNRNPUL2, EFTUD2 | ERN1 157/4885MAOB 4230/4885TRPM4 3240/4885 |
| US-20160107996-A1 | Mitochondrial Aldehyde Dehyrogenase-2 Modulators and Methods of Use Thereof | ALDH2, ALDH5A1, SHMT2 | ERN1 3759/4885MAOB 518/4885TRPM4 4625/4885 |
| US-20260093180-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE AND COMPOSITION FOR FILM FORMATION | SMC4, TYR, SMC2 | ERN1 2934/4885MAOB 175/4885TRPM4 506/4885 |
| US-20230100082-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | KLKB1, KLK5, KLK1 | ERN1 978/4885MAOB 594/4885TRPM4 3716/4885 |
| US-20210024526-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | ERN1 3673/4885MAOB 2061/4885TRPM4 505/4885 |
| US-20180354906-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | KLKB1, KLK1, KLK5 | ERN1 1030/4885MAOB 621/4885TRPM4 3656/4885 |
| US-20110105602-A2 | Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof | ALDH2, ALDH5A1, AK2 | ERN1 4380/4885MAOB 492/4885TRPM4 1641/4885 |
| US-20020183327-A1 | Bicyclic imidazo-3-yl-amine derivatives substituted on the 6-membered ring | OPRK1, GRIN3A, OPRM1 | ERN1 4009/4885MAOB 372/4885TRPM4 1630/4885 |
| US-20150182511-A1 | MODULATORS OF ALDEHYDE DEHYDROGENASE ACTIVITY AND METHODS OF USE THEREOF | ALDH2, ALDH3A1, ALDH1A1 | ERN1 3995/4885MAOB 140/4885TRPM4 2874/4885 |
| US-20130331396-A1 | PIPERAZINYL AND PIPERIDINYL UREAS AS MODULATORS OF FATTY ACID AMIDE HYDROLASE | FAAH, FAAH2, USP47 | ERN1 2606/4885MAOB 359/4885TRPM4 2109/4885 |
| US-20140248561-A1 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | ADH1C, ADH1A, FABP6 | ERN1 3856/4885MAOB 1437/4885TRPM4 4687/4885 |
| US-20140343045-A1 | Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof | ALDH2, ALDH3A1, ALDH1A1 | ERN1 4409/4885MAOB 200/4885TRPM4 3906/4885 |
| US-10889554-B2 | Excimer forming compounds | PHAX, RNMT, POLM | ERN1 120/4885MAOB 4396/4885TRPM4 1825/4885 |
| US-11203574-B2 | Human plasma kallikrein inhibitors | KLKB1, KLK5, KLK1 | ERN1 978/4885MAOB 594/4885TRPM4 3716/4885 |
| US-20030069265-A1 | Therapeutics for chemokine mediated diseases | CCR8, CCR2, CCR1 | ERN1 3963/4885MAOB 4745/4885TRPM4 414/4885 |
| US-20140142044-A1 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | PLK1, PLK4, PLK3 | ERN1 1452/4885MAOB 4213/4885TRPM4 3982/4885 |
| US-20150182506-A1 | Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof | ALDH2, ALDH3A1, ALDH1A1 | ERN1 4409/4885MAOB 200/4885TRPM4 3906/4885 |
| US-10364221-B2 | Monomer, organic layer composition, organic layer, and method of forming patterns | MSMO1, NOM1, CD68 | ERN1 3018/4885MAOB 1041/4885TRPM4 2543/4885 |
| US-12116346-B2 | Human plasma kallikrein inhibitors | KLKB1, KLK5, KLK1 | ERN1 889/4885MAOB 588/4885TRPM4 3424/4885 |
| US-20250270171-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | KLKB1, KLK5, KLK1 | ERN1 889/4885MAOB 588/4885TRPM4 3424/4885 |
| US-11569461-B2 | Organic electroluminescence device and organometallic compound for organic electroluminescence device | CHRM1, L1CAM, CHRM4 | ERN1 505/4885MAOB 2267/4885TRPM4 71/4885 |
| US-11420991-B2 | Confined porphyrin Co(II) and preparation method and application thereof | PPOX, PPIF, PPIC | ERN1 4827/4885MAOB 694/4885TRPM4 1562/4885 |
| US-20240150296-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | KLKB1, KLK5, KLK1 | ERN1 889/4885MAOB 588/4885TRPM4 3424/4885 |
| US-20130253010-A1 | Modulators of Aldhehyde Dehydrogenase Activity and Methods of Use Thereof | ALDH2, ALDH3A1, ALDH1A1 | ERN1 4291/4885MAOB 204/4885TRPM4 2503/4885 |
| US-20120065146-A1 | PEPTIDE MIMETIC LIGANDS OF POLO-LIKE KINASE 1 POLO BOX DOMAIN AND METHODS OF USE | PLK1, PLK2, PLK4 | ERN1 522/4885MAOB 4240/4885TRPM4 4156/4885 |
| US-20170008843-A1 | MONOMER, ORGANIC LAYER COMPOSITION, ORGANIC LAYER, AND METHOD OF FORMING PATTERNS | MSMO1, NOM1, CD68 | ERN1 3018/4885MAOB 1041/4885TRPM4 2543/4885 |
| US-11708332-B2 | Human plasma kallikrein inhibitors | KLKB1, KLK5, KLK1 | ERN1 978/4885MAOB 594/4885TRPM4 3716/4885 |
| US-20210403470-A1 | NOVEL METHODS FOR PREPARATION OF SUBSTITUTED PYRIDINES AND RELATED NOVEL COMPOUNDS | WEE1, WEE2, THEM6 | ERN1 3985/4885MAOB 1333/4885TRPM4 2153/4885 |
| US-20130267501-A1 | Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof | ALDH2, ALDH3A1, ALDH1A1 | ERN1 4409/4885MAOB 200/4885TRPM4 3906/4885 |
| US-20050130941-A1 | Methods of treating alzheimer's disease | BACE1, PSEN1, BACE2 | ERN1 3217/4885MAOB 125/4885TRPM4 3520/4885 |
| US-10329260-B2 | Human plasma kallikrein inhibitors | KLKB1, KLK1, KLK5 | ERN1 1030/4885MAOB 621/4885TRPM4 3656/4885 |
| US-20190181358-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | CHRM1, L1CAM, CHRM4 | ERN1 505/4885MAOB 2267/4885TRPM4 71/4885 |
| US-10125102-B2 | Human plasma kallikrein inhibitors | KLKB1, KLK1, KLK5 | ERN1 1030/4885MAOB 621/4885TRPM4 3656/4885 |
| US-20160176840-A1 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | ADH1C, ADH1A, FABP6 | ERN1 4201/4885MAOB 676/4885TRPM4 4536/4885 |
| US-10266565-B2 | Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use | PLK1, POLK, POLD3 | ERN1 169/4885MAOB 3821/4885TRPM4 4239/4885 |
| US-20090253656-A1 | BCRP/ABCG2 INHIBITOR | ABCC1, ABCB1, BRCA1 | ERN1 2040/4885MAOB 2516/4885TRPM4 1606/4885 |
| US-20170057982-A1 | MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 BINDING COMPOUNDS AND METHODS OF USE THEREOF | ALDH2, DLD, ALDH5A1 | ERN1 4070/4885MAOB 676/4885TRPM4 4692/4885 |
| US-20230192695-A1 | THERMALLY ASSISTED DELAYED FLUORESCENT MATERIALS WITH TRIAD-TYPE MATERIALS | TTPA, TTC14, AAAS | ERN1 3673/4885MAOB 2061/4885TRPM4 505/4885 |
| US-11192861-B2 | Human plasma kallikrein inhibitors | KLKB1, KLK5, KLK1 | ERN1 978/4885MAOB 594/4885TRPM4 3716/4885 |
| US-20170183279-A1 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | ADH1C, FABP6, ADH1A | ERN1 3999/4885MAOB 818/4885TRPM4 4448/4885 |
| US-20250011330-A1 | Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors | TDP1, TDP2, TOP1 | ERN1 286/4885MAOB 1589/4885TRPM4 4383/4885 |
| US-20210401803-A1 | COMPOUNDS AND USES THEREOF | CFTR, FPR1, CFB | ERN1 2294/4885MAOB 228/4885TRPM4 3597/4885 |
| US-20210155650-A1 | CONFINED PORPHYRIN CO(II) AND PREPARATION METHOD AND APPLICATION THEREOF | PPOX, PPIF, PPIC | ERN1 4827/4885MAOB 694/4885TRPM4 1562/4885 |
| US-11117893-B2 | Methods for preparation of substituted pyridines and related novel compounds | NNMT, CYP4F3, AGPS | ERN1 3799/4885MAOB 888/4885TRPM4 2372/4885 |
| US-20060173184-A1 | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase | FAAH, FAAH2, USP47 | ERN1 2606/4885MAOB 359/4885TRPM4 2109/4885 |
| US-20210047275-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | KLKB1, KLK5, KLK1 | ERN1 978/4885MAOB 594/4885TRPM4 3716/4885 |
| US-20170073314-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | KLKB1, KLK1, KLK5 | ERN1 1030/4885MAOB 621/4885TRPM4 3656/4885 |
| US-20190322626-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | KLKB1, KLK1, KLK5 | ERN1 1030/4885MAOB 621/4885TRPM4 3656/4885 |
| US-20210047276-A1 | HUMAN PLASMA KALLIKREIN INHIBITORS | KLKB1, KLK5, KLK1 | ERN1 978/4885MAOB 594/4885TRPM4 3716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.